Head-to-head · Cost-Efficiency Index
Neuvé Health vs SexyMD
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Neuvé Health
Readers who want the route and the base chosen explicitly and will ask what the monthly figure covers before enrolling.
Visit Neuvé HealthSexyMD
Readers willing to commit 48 weeks up front, where the advertised figure is the one actually charged.
Visit SexyMDThe verdict
Neuvé Health and SexyMD tie on the Cost-Efficiency Index at 68/100, so neither wins outright on the numbers. For most shoppers we'd start with Neuvé Health (ranked #118, a hair above #119) — Readers who want the route and the base chosen explicitly and will ask what the monthly figure covers before enrolling. But SexyMD is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Neuvé Health.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Neuvé Health | SexyMD |
|---|---|---|
| Cost-Efficiency Index | 68/100 | 68/100 |
| Semaglutide / mo | $217/month (standard injectable with B12; the site gives three different answers on whether the medication is inside the figure) | $269/mo on the four-week plan (the site's "from $199" is the 48-week commitment rate) |
| Tirzepatide / mo | $324/month (standard injectable with B12; same unresolved question about what the figure covers) | $369/mo on the four-week plan (the site's "from $299" is the 48-week commitment rate) |
| Semaglutide / yr (modeled) | $2,604 | $3,228 |
| Tirzepatide / yr (modeled) | $3,888 | $4,428 |
| Coverage | All 50 states | 47 states |
| Oral / sublingual | Yes | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #118 | #119 |
Neuvé Health
68/100Where the value is
- Prices twelve distinct GLP-1 products before any account: injectable and sublingual, standard and low dose, with a B12 or a B12-free glycine base for each
- States the 503A and 503B compounding classes on the homepage and the About page, which the August record did not find
- Names its founder as a nurse practitioner with a care role rather than referring only to an anonymous network
The tradeoffs
- Three surfaces disagree on whether the medication is inside the monthly price: the weight-loss page is headed "All-in monthly pricing" and lists the compounded drug as included, while its own fine print and the financial policy say medication, labs and supplies are billed separately
- The clinical partner that would settle that question — and that bills for the medication, the labs and the consultation — is never named
SexyMD
68/100Where the value is
- Publishes a full four-rung price table for each molecule on its product pages, before any intake
- States both pharmacy classes it uses and discloses that a prescription may be routed to, and transferred between, any pharmacy in that network
- Names the professional entities its prescribers work through, rather than referring only to licensed providers
The tradeoffs
- Every headline on the site quotes the 48-week rate: "from $199 per month" against a four-week price of $269, and "from $299" against $369, with an asterisk that resolves to no footnote
- The same footer block says both "available in all 50 states" and "available in all states except Arkansas, Mississippi, and New Jersey", on all eleven pages
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.